Stephanie Gentile's practice focuses on taxation of partnerships and corporations in a wide variety of business matters, including mergers and acquisitions for strategic acquirors and private equity sponsors, fund formations and restructurings.
Cooley Advises Investor Syndicate on $2.25 Billion Acquisition of HistoSonics
August 7, 2025
Cooley advised a syndicate of globally recognized private and public investors in connection with the management-led majority stake acquisition of HistoSonics, the developer of the Edison Histotripsy System and novel histotripsy therapy platform, valuing the company at approximately $2.25 billion.
Cooley advised Founders Fund, a San Francisco-based venture capital firm, on the close of its $4.6 billion third growth fund, Founders Fund Growth III.
Inmagene Biopharmaceuticals Completes Merger With Ikena Oncology [UPDATED]
July 25, 2025
Cooley advised Inmagene Biopharmaceuticals, a privately held, global clinical-stage biotechnology company developing novel therapeutics for immunological and inflammatory diseases, on its definitive merger agreement with Ikena Oncology (Nasdaq: IKNA).
CallidusAI Raises $10 Million to Accelerate the Future of AI-Powered Litigation
July 15, 2025
Cooley advised CallidusAI, Inc., a legal technology startup that developed an artificial intelligence platform for litigation tasks, on securing $10 million in new funding.
Sentinel Global Closes $213.5 Million Inaugural Fund
June 24, 2025
Cooley advised Sentinel Global, a venture capital firm dedicated to connecting visionary founders with real-world adopters, on the close of its inaugural fund, Sentinel Fund I, with committed capital totaling $213.5 million.
